US biotech major Amgen (Nasdaq: AMGN) has announced its plans to establish the production of its antitumor drug blinatumomab at the facilities of Russian Pharmstandard next year, according to the companies, reports The Pharma Letter’s local correspondent.
The Concern Intel Co Holding (Neral Company Group), owning 100% of shares in the Belebey Dairy, intends to sell the majority stake to the French Sevencia Fromage & Dairy Company Group. This information has been disclosed by the Dairy’s press service. The relevant letter of intent was signed by Ernst Isaev, the President of the Neral Company Group, and Alex Bongrain, the President of the French Company Group.
Takeda Pharmaceutical and Pharmstandard, JSC started cooperation on localizing the production of the onco-hematological drug Adcetris (brentuximab vedotin) at the Ufa-based plant.
The list of the Bashkortostan priority investment projects has been added with two facilities with a total amount of investment of about 1.5 billion rubles and 168 new jobs.
The capital of Bashkortostan launched a new shop of Witzenmann Russia, a Russian-German joint stock venture. The Company participates in the campaign “100 Investment Projects to the 100th Anniversary of the Republic of Bashkortostan”. The site of 1,480 sq. meters will host the production of compensators with a diameter of 1,200-3,000 mm for use in the petroleum, petrochemical, metallurgical, energy (thermal and nuclear power engineering) industries, as reported by the Capital’s administration.
The day before, in Moscow, the Government of Bashkortostan signed a cooperation agreement with the Vietnamese TH Group. The foreign investors plan to build in the republic a modern complex for the production of milk on the basis of one of the republican farms in the Budzyak District. This project also provides for rental of agricultural land to breed a domestic cattle stock.